← All stories
Policy
GSK Has Stacked Up Regulatory Wins This Week — So Why Are Its Shares Still Treading Water?
Highlights A first global clearance arrived for its chronic hepatitis programme in Japan. Regulators in the United States accepted a priority review filing in oncology. A paediatric HIV label extension added support to an established franch…
Covered by 1 outlet
All coverage · 1 article